Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,529 | 183 | 60.9% |
| Consulting Fee | $3,000 | 1 | 28.0% |
| Travel and Lodging | $1,093 | 6 | 10.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $99.73 | 1 | 0.9% |
| Education | $5.25 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $6,284 | 34 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,524 | 61 | $0 (2020) |
| Alkermes, Inc. | $625.99 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $576.37 | 17 | $0 (2021) |
| AbbVie Inc. | $427.67 | 14 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $349.00 | 10 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $226.08 | 11 | $0 (2022) |
| ITI, Inc. | $143.98 | 7 | $0 (2022) |
| Shire North American Group Inc | $122.95 | 7 | $0 (2019) |
| Indivior Inc. | $114.98 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $461.96 | 6 | Neurocrine Biosciences, Inc. ($308.04) |
| 2023 | $668.81 | 9 | Neurocrine Biosciences, Inc. ($328.21) |
| 2022 | $624.78 | 17 | Janssen Pharmaceuticals, Inc ($173.18) |
| 2021 | $1,123 | 32 | Neurocrine Biosciences, Inc. ($485.09) |
| 2020 | $520.38 | 15 | Neurocrine Biosciences, Inc. ($190.58) |
| 2019 | $769.28 | 14 | Neurocrine Biosciences, Inc. ($386.78) |
| 2018 | $5,470 | 52 | Neurocrine Biosciences, Inc. ($4,415) |
| 2017 | $1,089 | 48 | Sunovion Pharmaceuticals Inc. ($588.50) |
All Payment Transactions
193 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: CNS | ||||||
| 06/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $119.07 | General |
| Category: CNS | ||||||
| 05/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $80.86 | General |
| Category: Neuropsychiatry | ||||||
| 05/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $104.59 | General |
| Category: Neuropsychiatry | ||||||
| 03/07/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: CNS | ||||||
| 03/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $122.59 | General |
| Category: Neuropsychiatry | ||||||
| 09/13/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: CNS | ||||||
| 07/10/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: CNS | ||||||
| 06/28/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: Neuropsychiatry | ||||||
| 06/13/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: CNS | ||||||
| 05/04/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $64.74 | General |
| Category: Neuropsychiatry | ||||||
| 04/21/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $138.62 | General |
| Category: Neuropsychiatry | ||||||
| 03/28/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: CNS | ||||||
| 03/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.28 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $118.09 | General |
| Category: Neuroscience | ||||||
| 12/13/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $55.09 | General |
| Category: Neuroscience | ||||||
| 12/13/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Neuropsychiatry | ||||||
| 11/23/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: CNS | ||||||
| 07/20/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: PSYCHIATRY | ||||||
| 07/14/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: CNS | ||||||
| 05/27/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: PSYCHIATRY | ||||||
| 05/26/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Central Nervous System | ||||||
| 05/09/2022 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $139.61 | General |
| 05/05/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 28 | 90 | $8,585 | $6,731 |
| 2022 | 3 | 134 | 501 | $48,921 | $38,655 |
| 2021 | 3 | 167 | 975 | $106,487 | $74,490 |
| 2020 | 3 | 168 | 1,125 | $108,912 | $75,363 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 55 | $5,847 | $4,584 | 78.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 13 | 35 | $2,739 | $2,147 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 251 | $27,675 | $21,889 | 79.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 57 | 215 | $17,649 | $13,916 | 78.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 18 | 35 | $3,596 | $2,850 | 79.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 488 | $60,075 | $41,852 | 69.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 60 | 339 | $29,965 | $20,914 | 69.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 41 | 148 | $16,447 | $11,724 | 71.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 74 | 563 | $56,020 | $39,041 | 69.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 73 | 492 | $44,918 | $30,967 | 68.9% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 21 | 70 | $7,974 | $5,355 | 67.2% |
About Dr. Seeth Vivek, MD
Dr. Seeth Vivek, MD is a Psychiatry healthcare provider based in Jamaica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568404010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seeth Vivek, MD has received a total of $10,727 in payments from pharmaceutical and medical device companies, with $461.96 received in 2024. These payments were reported across 193 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($6,529).
As a Medicare-enrolled provider, Vivek has provided services to 497 Medicare beneficiaries, totaling 2,691 services with total Medicare billing of $195,239. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Jamaica, NY
- Active Since 06/11/2006
- Last Updated 07/21/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568404010
Products in Payments
- INGREZZA (Drug) $6,145
- LATUDA (Drug) $1,513
- VRAYLAR (Drug) $443.95
- REXULTI (Drug) $411.04
- ARISTADA (Drug) $347.54
- LYBALVI (Drug) $255.15
- ABILIFY MAINTENA (Drug) $242.34
- AUSTEDO (Drug) $226.08
- SPRAVATO (Drug) $196.97
- INVEGA SUSTENNA (Drug) $152.03
- CAPLYTA (Drug) $143.98
- SUBOXONE SUBLINGUAL FILM (Drug) $114.98
- VYVANSE (Drug) $103.54
- NEUROSTAR TMS THERAPY (Device) $85.32
- APLENZIN (Drug) $61.43
- Trintellix (Drug) $40.02
- Vivitrol 380 mg (Drug) $23.30
- UBRELVY (Drug) $21.16
- MYDAYIS (Drug) $19.41
- BELSOMRA (Drug) $16.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Jamaica
Sanford Herman
Psychiatry — Payments: $832,093
Zelimir Vukasin, Md, MD
Psychiatry — Payments: $79,529
Aggy Vallanat, Md, MD
Psychiatry — Payments: $33,439
Dr. Hammad Mohsin, M.d, M.D
Psychiatry — Payments: $5,698
Dr. Karamchand Rameshwar, M.d, M.D
Psychiatry — Payments: $3,091
Dr. Xiaoling Song, M.d, M.D
Psychiatry — Payments: $2,635